Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-04 8:12 pm Unchanged | 2026-09-04 | 13G | VALION BIO, INC. VBIO | 3i, LP | 132,671 9.900% | 0 (Unchanged) | Filing History |
| 2026-09-03 8:30 pm Sale | 2026-09-03 | 13D | VALION BIO, INC. VBIO | 3i, LP | 132,671 9.900% | -334 (-0.25%) | Filing History |
| 2026-09-02 8:51 pm Sale | 2026-08-31 | 13D | VALION BIO, INC. VBIO | 3i, LP | 133,005 9.900% | -361 (-0.27%) | Filing History |
| 2026-08-27 8:33 pm Purchase | 2026-08-25 | 13D | VALION BIO, INC. VBIO | 3i, LP | 133,366 9.900% | 49,255 (+58.56%) | Filing History |
| 2026-08-24 7:41 pm Purchase | 2026-08-20 | 13D | VALION BIO, INC. VBIO | 3i, LP | 84,111 9.900% | 2,103 (+2.56%) | Filing History |
| 2026-08-19 9:09 pm Purchase | 2026-08-17 | 13D | VALION BIO, INC. VBIO | 3i, LP | 82,008 9.900% | 12,300 (+17.65%) | Filing History |
| 2026-08-14 7:15 pm Purchase | 2026-08-12 | 13D | VALION BIO, INC. VBIO | 3i, LP | 69,708 9.900% | 51,838 (+290.08%) | Filing History |
| 2026-08-14 5:00 pm Purchase | 2026-06-30 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 169,341,400 9.900% | 44,395,025 (+35.53%) | Filing History |
| 2026-08-11 4:05 pm Unchanged | 2026-08-09 | 13D | VALION BIO, INC. VBIO | 3i, LP | 17,870 9.900% | 0 (Unchanged) | Filing History |
| 2026-08-03 07:01 am Purchase | 2026-07-28 | 13D | VALION BIO, INC. VBIO | 3i, LP | 17,870 9.900% | 5,569 (+45.27%) | Filing History |
| 2026-05-08 5:10 pm Sale | 2026-03-31 | 13G | NETCAPITAL INC NCPL | 3i, LP | 505,935 6.100% | -12,954 (-2.50%) | Filing History |
| 2026-05-08 5:07 pm Purchase | 2026-03-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 124,946,375 9.900% | 41,350,834 (+49.47%) | Filing History |
| 2026-05-08 5:02 pm Purchase | 2026-03-31 | 13G | VALION BIO, INC. VBIO | 3i, LP | 12,301 9.900% | 1,254 (+11.35%) | Filing History |
| 2026-05-07 8:00 pm Purchase | 2026-03-31 | 13G | PELTHOS THERAPEUTICS INC PTHS | 3i, LP | 337,026 9.900% | 18,140 (+5.69%) | Filing History |
| 2026-04-23 4:05 pm Purchase | 2026-04-22 | 13G | CAPSTONE THERAPEUTICS CORP COM CAPS | 3i, LP | 1,271,220 9.900% | 1,271,220 (New Position) | Filing History |
| 2026-04-23 4:05 pm Purchase | 2026-04-21 | 13G | ZSPACE INC ZSPC | 3i, LP | 336,211 9.900% | 336,211 (New Position) | Filing History |
| 2026-02-27 4:05 pm Purchase | 2026-02-21 | 13G | VALION BIO, INC. VBIO | 3i, LP | 11,047 9.900% | 11,047 (New Position) | Filing History |
| 2026-02-05 4:08 pm Purchase | 2025-12-31 | 13G | PELTHOS THERAPEUTICS INC PTHS | 3i, LP | 318,886 9.900% | 15,748 (+5.19%) | Filing History |
| 2026-02-05 4:07 pm Purchase | 2025-12-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 83,595,541 9.900% | 2,730,297 (+3.38%) | Filing History |
| 2026-02-05 4:06 pm Unchanged | 2025-12-31 | 13G | SCORPIUS HLDGS INC PAR $0. SCPX | 3i, LP | 6,786,087 9.900% | 0 (Unchanged) | Filing History |